Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2019-02-03 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 10Q for Qtr ended December 31, 2018 37 pages 342.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' for the quarterly period ended December 31, 2018. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, income statements, cash flow statements, notes to the financial statements, and management's discussion and analysis. The length of the document is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. Therefore, the correct classification is 'IR'. Q2 2019
2019-02-03 English
Appendix 3B 8 pages 431.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to securities issuance and quotation. It details the issuance of new securities, number of securities, issue price, purpose, and application for quotation on the ASX. The content is consistent with a formal announcement of new share issues and capital changes rather than a financial report or earnings release. There is no financial statement or management discussion, but rather regulatory compliance information about securities issuance. This matches the definition of 'Share Issue/Capital Change' filings. The document length and detail confirm it is the announcement itself, not a brief notice or report publication announcement.
2019-02-03 English
FORM 8K - Amendment No. 2 10 pages 98.0KB
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 2) filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It includes an explanatory note about the amendment, a revised Consent of Independent Auditor (Exhibit 23.1), and unaudited pro forma condensed combined financial information (Exhibit 99.2) related to the acquisition of MatrixCare Holdings, Inc. by ResMed Inc. The document contains detailed pro forma financial statements combining historical financials of both companies and adjustments reflecting the acquisition. The presence of pro forma financial information and auditor consent in an 8-K/A amendment indicates this is a regulatory filing updating prior disclosures about a significant acquisition and related financial data. It is not a full annual or quarterly report, nor is it a simple announcement or presentation. The document is substantive and detailed, not a brief announcement or certification. Therefore, the best classification is Regulatory Filings (RNS), as it is a current report amendment with pro forma financials and auditor consent, which do not fit other more specific categories like M&A Activity or Annual Report.
2019-01-30 English
FORM 8-K/A 28 pages 254.1KB
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, which is an amendment to a previously filed Form 8-K. It reports the completion of an acquisition (MatrixCare Holdings, Inc.) by ResMed Inc. and includes detailed financial statements of the acquired business (audited financials for 2017 and interim unaudited for 2018), pro forma financial information, and auditor's consent. The presence of audited financial statements and pro forma financials related to the acquisition indicates this is a current report on a significant event (acquisition) with financial disclosures. Form 8-K filings are current reports for material events and are not annual or quarterly reports themselves. This document is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is a regulatory filing reporting a material event with financial statements attached. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a current report amendment with financial disclosures related to an acquisition event, but not a merger proxy statement or tender offer filing (which would be MA or TAR).
2019-01-29 English
ResMed Announces Results for the Second Quarter of FY 2019 9 pages 199.5KB
Earnings Release Classification · 95% confidence The document is a detailed announcement of ResMed Inc.'s financial results for the second quarter of fiscal year 2019, including revenue, profit, earnings per share, and operational highlights. It contains unaudited financial statements such as condensed consolidated statements of income and balance sheets, with substantive financial data and analysis. The document also mentions a webcast of the earnings call but is itself a press release with comprehensive financial results, not just a transcript or a brief announcement. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights and financial metrics. Q2 2019
2019-01-24 English
Dividend/Distribution - RMD 4 pages 33.5KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related details. It does not contain financial statements or management discussion but is clearly an announcement of dividend payment details to shareholders. This matches the definition of 'Notice of Dividend Amount (DIV)', which covers announcements of dividend amounts, payment dates, and details for shareholders. The document length is about 4803 characters, which is sufficient for a detailed dividend announcement but not a full financial report. Therefore, the correct classification is DIV with high confidence.
2019-01-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.